Basic Information
RNALocate ID: RLID-D:11000139
RNA Symbol: hsa-miR-429
Localization: Exosome
RNA Information
RNA Name: hsa-miR-429
RNA ID: miRBase:MIMAT0001536
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
Tissue/Cell Line: Breast milk|Colon tissue|Seminal fluid|Tongue tissue
Database: EVmiRNA
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11002768 Exosome Serum 18589210
RLID:11002769 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11002770 Exosome Brain tissue 23382797
RLID:11002771 Exosome Plasma 23663360
RLID-D:11000452 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-mir-429 Oral squamous cell carcinoma MNDR-E-MI-49322
MNDR hsa-miR-429 Oral squamous cell carcinoma MNDR-E-MI-49323
MNDR hsa-miR-429 Large cell neuroendocrine cancer MNDR-E-MI-49324
MNDR hsa-miR-429 High-grade serous ovarian carcinoma MNDR-E-MI-49325
MNDR hsa-miR-429 Uterine corpus endometrial carcinoma MNDR-E-MI-49326
MNDR hsa-mir-429 Immunoglobulin a deficiency MNDR-E-MI-49327
MNDR hsa-mir-429 Non-hodgkin lymphoma somatic MNDR-E-MI-49328
MNDR hsa-miR-429 Estrogen-receptor positive breast cancer MNDR-E-MI-49329
MNDR hsa-miR-429 Estrogen-receptor negative breast cancer MNDR-E-MI-49330
MNDR hsa-miR-429 Progesterone-receptor positive breast cancer MNDR-E-MI-49331
MNDR hsa-miR-429 Progesterone-receptor negative breast cancer MNDR-E-MI-49332
MNDR hsa-miR-429 Her2-receptor positive breast cancer MNDR-E-MI-49333
MNDR hsa-miR-429 Breast cancer luminal MNDR-E-MI-49334
MNDR hsa-mir-429 Colorectal carcinoma MNDR-E-MI-49335
MNDR hsa-mir-429 Fatty liver non-alcoholic MNDR-E-MI-49336
MNDR hsa-mir-429 Prostate cancer MNDR-E-MI-49337
MNDR hsa-mir-429 Leukemia/lymphoma chronic b-cell MNDR-E-MI-49338
MNDR hsa-miR-429 Hirschsprung disease MNDR-E-MI-49339
MNDR hsa-mir-429 Gastric cancer MNDR-E-MI-49340
MNDR hsa-miR-429 Gastric cancer MNDR-E-MI-49341
MNDR hsa-miR-429 Alzheimer disease MNDR-E-MI-49342
MNDR hsa-mir-429 Bladder cancer MNDR-E-MI-49343
MNDR hsa-miR-429 Bladder cancer MNDR-E-MI-49344
MNDR hsa-mir-429 Carcinoma esophageal MNDR-E-MI-49345
MNDR hsa-miR-429 Gilles de la tourette syndrome MNDR-E-MI-49346
MNDR hsa-mir-429 Nephrosclerosis MNDR-E-MI-49347
MNDR hsa-mir-429 Cardiomyopathy dilated MNDR-E-MI-49348
MNDR hsa-miR-429 Lung cancer MNDR-E-MI-49349
MNDR hsa-mir-429 Lung cancer MNDR-E-MI-49350
MNDR hsa-mir-429 Endometrial cancer MNDR-E-MI-49351
MNDR hsa-miR-429 Endometrial cancer MNDR-E-MI-49352
MNDR hsa-mir-429 Azoospermia MNDR-E-MI-49353
MNDR hsa-miR-429 Parkinson disease MNDR-E-MI-49354
MNDR hsa-miR-429 Machado-joseph disease MNDR-E-MI-49355
MNDR hsa-miR-429 Basal-like breast cancer MNDR-E-MI-49356
MNDR hsa-mir-429 Breast cancer MNDR-E-MI-49357
MNDR hsa-mir-429 Cancer MNDR-E-MI-49358
MNDR hsa-miR-429 Cancer MNDR-E-MI-49359
MNDR hsa-miR-429 Thyroid cancer MNDR-E-MI-49360
MNDR hsa-miR-429 Pituitary neoplasms MNDR-E-MI-49361
MNDR hsa-mir-429 Pancreatic cancer MNDR-E-MI-49362
MNDR hsa-miR-429 Pancreatic cancer MNDR-E-MI-49363
MNDR hsa-mir-429 Malignant melanoma MNDR-E-MI-49364
MNDR hsa-miR-429 Melanoma MNDR-E-MI-49365
MNDR hsa-miR-429 Rectum adenocarcinoma MNDR-E-MI-49366
MNDR hsa-mir-429 Nephroblastoma MNDR-E-MI-49367
MNDR hsa-miR-429 Nephroblastoma MNDR-E-MI-49368
MNDR hsa-miR-429 Colon cancer MNDR-E-MI-49369
MNDR hsa-mir-429 Colon cancer MNDR-E-MI-49370
MNDR hsa-miR-429 Colon adenocarcinoma MNDR-E-MI-49371
MNDR hsa-mir-429 Ovarian cancer MNDR-E-MI-49372
MNDR hsa-miR-429 Ovarian cancer MNDR-E-MI-49373
MNDR hsa-mir-429 Adenocarcinoma endometrial MNDR-E-MI-49374
MNDR hsa-miR-429 Endometrial endometrioid carcinoma MNDR-E-MI-49375
MNDR hsa-mir-429 Endometriosis MNDR-E-MI-49376
MNDR hsa-mir-429 Glomerulonephritis MNDR-E-MI-49377
MNDR hsa-mir-429 Iga glomerulonephritis MNDR-E-MI-49378
MNDR hsa-mir-429 Adenocarcinoma MNDR-E-MI-49379
MNDR hsa-miR-429 Carcinoma ductal breast MNDR-E-MI-49380
MNDR hsa-mir-429 Glioblastoma MNDR-E-MI-49381
MNDR hsa-mir-429 Astrocytoma MNDR-E-MI-49382
MNDR hsa-mir-429 Glioma MNDR-E-MI-49383
MNDR hsa-miR-429 Malignant glioma MNDR-E-MI-49384
MNDR hsa-miR-429 Temporal lobe epilepsy MNDR-E-MI-49385
MNDR hsa-mir-429 Osteosarcoma MNDR-E-MI-49386
MNDR hsa-mir-429 Mesenchymal cancer MNDR-E-MI-49387
MNDR hsa-miR-429 Pediatric osteosarcoma MNDR-E-MI-49388
MNDR hsa-miR-429 Liposarcoma MNDR-E-MI-49389
MNDR hsa-miR-429 Breast carcinoma MNDR-E-MI-49390
MNDR hsa-mir-429 Adenocarcinoma pancreatic ductal MNDR-E-MI-49391
MNDR hsa-miR-429 Liver cancer MNDR-E-MI-49392
MNDR hsa-mir-429 Liver neoplasms MNDR-E-MI-49393
MNDR hsa-miR-429 Cervical adenocarcinoma MNDR-E-MI-49394
MNDR hsa-miR-429 Gastric adenocarcinoma MNDR-E-MI-49395
MNDR hsa-miR-429 Cervical squamous cell carcinoma MNDR-E-MI-49396
MNDR hsa-miR-429 Pituitary adenoma MNDR-E-MI-49397
MNDR hsa-miR-429 Lung squamous cell carcinoma MNDR-E-MI-49398
MNDR hsa-mir-429 Carcinoma lung non-small-cell MNDR-E-MI-49399
MNDR hsa-miR-429 Carcinoma lung non-small-cell MNDR-E-MI-49400
MNDR hsa-mir-429 Lung adenocarcinoma MNDR-E-MI-49401
MNDR hsa-miR-429 Lung adenocarcinoma MNDR-E-MI-49402
MNDR hsa-miR-429 Thyroid carcinoma MNDR-E-MI-49403
MNDR hsa-miR-429 Papillary thyroid cancer MNDR-E-MI-49404
MNDR hsa-miR-429 Ovarian carcinoma MNDR-E-MI-49405
MNDR hsa-miR-429 Bladder urothelial carcinoma MNDR-E-MI-49406
MNDR hsa-mir-429 Cervical cancer MNDR-E-MI-49407
MNDR hsa-mir-429 Carcinoma renal cell MNDR-E-MI-49408
MNDR hsa-miR-429 Carcinoma renal cell MNDR-E-MI-49409
MNDR hsa-miR-429 Kidney renal papillary cell carcinoma MNDR-E-MI-49410
MNDR hsa-miR-429 Clear cell renal cell carcinoma MNDR-E-MI-49411
MNDR hsa-miR-429 Biliary tract cancer MNDR-E-MI-49412
MNDR hsa-miR-429 Intrahepatic cholangiocarcinoma MNDR-E-MI-49413
MNDR hsa-miR-429 Cholangiocarcinoma MNDR-E-MI-49414
MNDR hsa-miR-429 Esophageal cancer MNDR-E-MI-49415
MNDR hsa-mir-429 Carcinoma ehrlich tumor MNDR-E-MI-49416
MNDR hsa-miR-429 Lung small cell carcinoma MNDR-E-MI-49417
MNDR hsa-miR-429 Gastric carcinoma MNDR-E-MI-49418
MNDR hsa-miR-429 Testicular germ cell cancer MNDR-E-MI-49419
MNDR hsa-mir-429 Heart failure MNDR-E-MI-49420
MNDR hsa-miR-429 Breast invasive carcinoma MNDR-E-MI-49421
MNDR hsa-mir-429 Carcinoma hepatocellular MNDR-E-MI-49422
MNDR hsa-miR-429 Hepatocellular carcinoma MNDR-E-MI-49423
MNDR hsa-miR-429 Retinoblastoma MNDR-E-MI-49424
MNDR hsa-mir-429 Leukemia chronic myeloid MNDR-E-MI-49425
MNDR hsa-miR-429 Ulcerative colitis MNDR-E-MI-49426
MNDR hsa-mir-429 Mouth neoplasms MNDR-E-MI-49427
MNDR hsa-miR-429 Crohn disease MNDR-E-MI-49428
MNDR hsa-miR-429 Tonsil cancer MNDR-E-MI-49429
MNDR hsa-mir-429 Systemic lupus erythematosus MNDR-E-MI-49430
MNDR hsa-mir-429 Leukemia acute myeloid MNDR-E-MI-49431
MNDR hsa-mir-429 Barrett's esophagus MNDR-E-MI-49432
MNDR hsa-mir-429 Colorectal cancer MNDR-E-MI-49433
MNDR hsa-miR-429 Colorectal cancer MNDR-E-MI-49434
MNDR hsa-miR-429 Nasopharynx carcinoma MNDR-E-MI-49435
MNDR hsa-miR-429 Ovarian epithelial cancer MNDR-E-MI-49436
MNDR hsa-mir-429 Helplessness learned MNDR-E-MI-49437
MNDR hsa-miR-429 Nasopharyngeal cancer MNDR-E-MI-49438
MNDR hsa-mir-429 Myocardial ischemia MNDR-E-MI-49439
MNDR hsa-miR-429 Breast cancer her3+ negative MNDR-E-MI-49440
MNDR hsa-miR-429 Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-49441
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter BAP1 Homo sapiens RR00211603
TOP